Chemoinformaics analysis of (+)-Methyl pachybioside
| Molecular Weight | 336.381 | nRot | 5 |
| Heavy Atom Molecular Weight | 308.157 | nRig | 12 |
| Exact Molecular Weight | 336.178 | nRing | 2 |
| Solubility: LogS | -0.327 | nHRing | 2 |
| Solubility: LogP | -0.445 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 50.1362 |
| nHD | 2 | BPOL | 38.5058 |
| QED | 0.703 |
| Synth | 4.416 |
| Natural Product Likeliness | 2.673 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.049 |
| Pgp-sub | 0.785 |
| HIA | 0.076 |
| CACO-2 | -5.079 |
| MDCK | 0.0000932 |
| BBB | 0.193 |
| PPB | 0.136577 |
| VDSS | 0.517 |
| FU | 0.695037 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.663 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.809 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.029 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.19 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.357 |
| CL | 5.573 |
| T12 | 0.249 |
| hERG | 0.032 |
| Ames | 0.705 |
| ROA | 0.066 |
| SkinSen | 0.05 |
| Carcinogencity | 0.233 |
| EI | 0.01 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.800301 |